Product Name

  • Name

    Tenatoprazole

  • EINECS 601-277-6
  • CAS No. 113712-98-4
  • Article Data6
  • CAS DataBase
  • Density 1.41 g/cm3
  • Solubility
  • Melting Point 178-180°C
  • Formula C16H18N4O3S
  • Boiling Point 591.5 °C at 760 mmHg
  • Molecular Weight 346.41
  • Flash Point 311.5 °C
  • Transport Information
  • Appearance white crystalline powder
  • Safety 26-36/37
  • Risk Codes 22-36/37/38
  • Molecular Structure Molecular Structure of 113712-98-4 (Tenatoprazole)
  • Hazard Symbols HarmfulXn
  • Synonyms 1H-Imidazo[4,5-b]pyridine,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- (9CI);2-[2-((4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl]-5-methoxyimidazo[4,5-b]pyridine;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine;TU 199;3H-Imidazo[4,5-b]pyridine,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-;
  • PSA 109.20000
  • LogP 3.16040

Synthetic route

5-methoxy-2-[(4-nitro-3,5-dimethyl-2-pyridinyl)methylsulfinyl]imidazo[4,5-b]pyridine

5-methoxy-2-[(4-nitro-3,5-dimethyl-2-pyridinyl)methylsulfinyl]imidazo[4,5-b]pyridine

sodium methylate
124-41-4

sodium methylate

tenatoprazole
113712-98-4

tenatoprazole

Conditions
ConditionsYield
In methanol at -5℃; for 18h;79.4%
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine
113713-24-9

5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine

tenatoprazole
113712-98-4

tenatoprazole

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform at -15 - -10℃; Large scale reaction;74%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 1h;66.4%
With 3-chloro-benzenecarboperoxoic acid In chloroform
5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine
113713-24-9

5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine

A

5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfonyl)-1H-imidazo[4,5-b]pyridine

5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfonyl)-1H-imidazo[4,5-b]pyridine

B

tenatoprazole
113712-98-4

tenatoprazole

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform at 5℃; for 0.0166667h; Product distribution / selectivity;
tenatoprazole
113712-98-4

tenatoprazole

methyl iodide
74-88-4

methyl iodide

5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-ylmethanesulfinyl)-1-methyl-1H-imidazo[4,5-b]pyridine
721924-07-8

5-methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-ylmethanesulfinyl)-1-methyl-1H-imidazo[4,5-b]pyridine

Conditions
ConditionsYield
With dmap; potassium carbonate In dichloromethane at 25 - 30℃; for 10h;91.3%
tenatoprazole
113712-98-4

tenatoprazole

A

5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine
113713-24-9

5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylthio)-1H-imidazo[4,5-b]pyridine

B

5'-hydroxyltenatoprazole

5'-hydroxyltenatoprazole

C

5'-hydroxyltenatoprazole sulfide

5'-hydroxyltenatoprazole sulfide

Conditions
ConditionsYield
With D-glucose-6-; nicotinamide adenine dinucleotide phosphate; yeast glucose-6-phosphate dehydrogenase In aq. phosphate buffer at 37℃; pH=7.4; Catalytic behavior; Kinetics; Reagent/catalyst; Enzymatic reaction; regioselective reaction;A n/a
B 8.2%
C 1.3%
With G1T mutant of CYP102A1; NADPH In aq. phosphate buffer; dimethyl sulfoxide at 37℃; for 2h; pH=7.4; Reagent/catalyst; Time; Enzymatic reaction;
(4-chlorosulfonylphenoxy)acetic acid 2-(toluene-4-sulfonyl)ethyl ester
651728-13-1

(4-chlorosulfonylphenoxy)acetic acid 2-(toluene-4-sulfonyl)ethyl ester

tenatoprazole
113712-98-4

tenatoprazole

A

2-tosylethyl 2-{4-[5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-imidazo[4,5-b]pyridine-1-ylsulfonyl]-phenoxy}-acetate
1015067-31-8

2-tosylethyl 2-{4-[5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-imidazo[4,5-b]pyridine-1-ylsulfonyl]-phenoxy}-acetate

B

2-tosylethyl 2-{4-[5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-3H-imidazo[4,5-b]pyridine-3-ylsulfonyl]-phenoxy}-acetate
1015067-32-9

2-tosylethyl 2-{4-[5-methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-3H-imidazo[4,5-b]pyridine-3-ylsulfonyl]-phenoxy}-acetate

Conditions
ConditionsYield
With sodium hydrogencarbonate; triethylamine In dichloromethane at 20℃;
tenatoprazole
113712-98-4

tenatoprazole

(-)5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine

(-)5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine

Conditions
ConditionsYield
Resolution of racemate;
Resolution of racemate;
2-[(chlorocarbonyl)(methyl)amino]ethyl ethyl carbonate
635751-00-7

2-[(chlorocarbonyl)(methyl)amino]ethyl ethyl carbonate

tenatoprazole
113712-98-4

tenatoprazole

ethyl 2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl carbonate

ethyl 2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl carbonate

Conditions
ConditionsYield
With triethylamine; dmap In tetrahydrofuran at 60℃; for 6h;
With dmap; triethylamine In tetrahydrofuran at 60℃; for 6h;0.721 g
2-[(chlorocarbonyl) (phenyl)amino]ethyl acetate
635751-44-9

2-[(chlorocarbonyl) (phenyl)amino]ethyl acetate

tenatoprazole
113712-98-4

tenatoprazole

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](phenyl)amino]ethyl acetate

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](phenyl)amino]ethyl acetate

Conditions
ConditionsYield
With triethylamine; dmap In tetrahydrofuran at 60℃; for 10h;
With dmap; triethylamine In tetrahydrofuran at 60℃; for 10h;0.311 g
tenatoprazole
113712-98-4

tenatoprazole

(+)5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine

(+)5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-imidazo[4,5-b]pyridine

Conditions
ConditionsYield
Resolution of racemate;
2-(chlorocarbonyl(methyl)amino)ethyl acetate

2-(chlorocarbonyl(methyl)amino)ethyl acetate

tenatoprazole
113712-98-4

tenatoprazole

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl acetate

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl acetate

Conditions
ConditionsYield
With triethylamine; dmap In tetrahydrofuran at 60℃; for 5h;
With dmap; triethylamine In tetrahydrofuran at 60℃; for 5h;0.173 g
C11H11Cl2NO3

C11H11Cl2NO3

tenatoprazole
113712-98-4

tenatoprazole

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl 3-chlorobenzoate

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl 3-chlorobenzoate

Conditions
ConditionsYield
With triethylamine; dmap In tetrahydrofuran at 60℃; for 14h;
With dmap; triethylamine In tetrahydrofuran at 60℃; for 14h;0.360 g
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

1-acetoxy-2-methylaminoethane hydrochloride
4527-98-4

1-acetoxy-2-methylaminoethane hydrochloride

tenatoprazole
113712-98-4

tenatoprazole

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl acetate

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl acetate

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: 1-acetoxy-2-methylaminoethane hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 2h;
Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 5h;
2-(methylamino)ethyl 3-chlorobenzoate hydrochloride
635750-79-7

2-(methylamino)ethyl 3-chlorobenzoate hydrochloride

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

tenatoprazole
113712-98-4

tenatoprazole

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl 3-chlorobenzoate

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl 3-chlorobenzoate

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: 2-(methylamino)ethyl 3-chlorobenzoate hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 2.5h;
Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 14h;
ethyl 2-(methylamino)ethyl carbonate hydrochloride
635750-86-6

ethyl 2-(methylamino)ethyl carbonate hydrochloride

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

tenatoprazole
113712-98-4

tenatoprazole

ethyl 2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl carbonate

ethyl 2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](methyl)amino]ethyl carbonate

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: ethyl 2-(methylamino)ethyl carbonate hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 2.5h;
Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 6h;
2-anilinoethyl acetate hydrochloride
30761-89-8

2-anilinoethyl acetate hydrochloride

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

tenatoprazole
113712-98-4

tenatoprazole

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](phenyl)amino]ethyl acetate

2-[[[5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-3H-imidazo[4,5-b]pyridin-3-yl]carbonyl](phenyl)amino]ethyl acetate

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate With pyridine In tetrahydrofuran at 0℃; for 0.5h;
Stage #2: 2-anilinoethyl acetate hydrochloride With triethylamine In tetrahydrofuran at 15 - 30℃; for 3h;
Stage #3: tenatoprazole With dmap; triethylamine In tetrahydrofuran at 60℃; for 10h;
tenatoprazole
113712-98-4

tenatoprazole

5-methoxy 2-[[(4-methoxy-3,5-dimethyl)-2-pyridyl methyl]sulfinyl]1H imidazo[4,5-b]pyridine, potassium salt

5-methoxy 2-[[(4-methoxy-3,5-dimethyl)-2-pyridyl methyl]sulfinyl]1H imidazo[4,5-b]pyridine, potassium salt

Conditions
ConditionsYield
With potassium hydroxide In water at 0℃; for 12h; Product distribution / selectivity;
tenatoprazole
113712-98-4

tenatoprazole

A

5'-hydroxyltenatoprazole

5'-hydroxyltenatoprazole

B

5'-hydroxyltenatoprazole sulfide

5'-hydroxyltenatoprazole sulfide

Conditions
ConditionsYield
With G1T mutant of CYP102A1 for 0.5h; Kinetics; Reagent/catalyst; Enzymatic reaction;

Tenatoprazole Chemical Properties

Molecule structure of Tenatoprazole (CAS NO.113712-98-4):

IUPAC Name: 5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine 
Molecular Weight: 346.40412 g/mol
Molecular Formula: C16H18N4O3
Density: 1.41 g/cm3
Boiling Point: 591.5 °C at 760 mmHg 
Flash Point: 311.5 °C
Index of Refraction: 1.673
Molar Refractivity: 91.81 cm3
Molar Volume: 244.7 cm3
Surface Tension: 82.3 dyne/cm  
Enthalpy of Vaporization: 88.22 kJ/mol
Vapour Pressure: 5.8E-14 mmHg at 25 °C 
Storage Temp.: −20 °C
XLogP3-AA: 1.8
H-Bond Donor: 1
H-Bond Acceptor: 6
Rotatable Bond Count: 5
Tautomer Count: 3
Exact Mass: 346.109961
MonoIsotopic Mass: 346.109961
Topological Polar Surface Area: 90
Heavy Atom Count: 24
Canonical SMILES: CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=CC(=N3)OC
InChI: InChI=1S/C16H18N4O3S/c1-9-7-17-12(10(2)14(9)23-4)8-24(21)16-18-11-5-6-13(22-3)19-15(11)20-16/h5-7H,8H2,1-4H3,(H,18,19,20)
InChIKey: ZBFDAUIVDSSISP-UHFFFAOYSA-N
Product Categories: Heterocyclic Compounds; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds; API's

Tenatoprazole Uses

 Tenatoprazole (CAS NO.113712-98-4) is used as a proton pump inhibitor for reduction and/or prevention of gastrointestinal disorders.

Tenatoprazole Safety Profile

Hazard Codes: HarmfulXn
Risk Statements: 22-36/37/38 
R22:Harmful if swallowed. 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36/37 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36/37:Wear suitable protective clothing and gloves.

Tenatoprazole Specification

 Tenatoprazole (CAS NO.113712-98-4) is also named as (+-)-5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine ; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine ; Protop ; Tu 199 ; UNII-RE0689TX2K ; Ulsacare ; 1H-Imidazo(4,5-b)pyridine, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)- . Tenatoprazole (CAS NO.113712-98-4) is white crystalline powder. It is an imidazopyridine derivative and has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View